HU203343B - Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
- Google Patents
Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
Info
Publication number
HU203343B
HU203343BHU347389AHU347389AHU203343BHU 203343 BHU203343 BHU 203343BHU 347389 AHU347389 AHU 347389AHU 347389 AHU347389 AHU 347389AHU 203343 BHU203343 BHU 203343B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon VegyeszetfiledCriticalRichter Gedeon Vegyeszet
Priority to HU347389ApriorityCriticalpatent/HU203343B/hu
Publication of HU203343BpublicationCriticalpatent/HU203343B/hu
HU347389A1989-07-111989-07-11Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
HU203343B
(en)
Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
Process for the preparation of optically pure s-(-)-1-propyl-2:,6:-pipecoloxylidide hydrochloride monohydrate and of pharmaceutical compositions containing the same
Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
Process for producing 1,3-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic compositions containing them as active components
Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
Process for producing 1-amino-alkyl-3-oxy-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-one derivatives and pharmaceutical compositions containing them as active components
Legal Events
Date
Code
Title
Description
HMM4
Cancellation of final prot. due to non-payment of fee